Norris Medicines Ltd vs Remedium Lifecare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Norris Medicines Ltd is ₹ 14.11 as of 12 Jun 15:30 . The P/E Ratio of Norris Medicines Ltd is 0 as of March 2025 .The P/E Ratio of Remedium Lifecare Ltd is 36.4 as of March 2025 . The Market Cap of Norris Medicines Ltd is ₹ 0 crore as of March 2025 .The Market Cap of Remedium Lifecare Ltd is ₹ 73.38 crore as of March 2025 . The Revenue of Norris Medicines Ltd is ₹ 0 crore as of Mar '25 .The Revenue of Remedium Lifecare Ltd is ₹ 264.98 crore as of Mar '25 . The EBITDA of Norris Medicines Ltd is ₹ 0 crore as of Mar '25 .The EBITDA of Remedium Lifecare Ltd is ₹ 0.2 crore as of Mar '25 . The Net Profit of Norris Medicines Ltd is ₹ 0 crore as of Mar '25 .The Net Profit of Remedium Lifecare Ltd is ₹ -2.05 crore as of Mar '25 . The Dividend Payout of Norris Medicines Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Norris Medicines Ltd

Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments.
The Company was subsequently converted into Public Limited Company on March 7, 1992.
The unit expanded to manufacture Sterile dosage in form of Ampoules & Vials. The Company got into the business in the year 1990.
Commercial production of the formulation unit commenced in Nov.'91.
The production unit expanded to manufacture Sterile dosage in form of Ampoules & Vials.

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

FAQs for the comparison of Norris Medicines Ltd and Remedium Lifecare Ltd

Which company has a larger market capitalization, Norris Medicines Ltd or Remedium Lifecare Ltd?

Market cap of Norris Medicines Ltd is 14 Cr while Market cap of Remedium Lifecare Ltd is 24 Cr

What are the key factors driving the stock performance of Norris Medicines Ltd and Remedium Lifecare Ltd?

The stock performance of Norris Medicines Ltd and Remedium Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Norris Medicines Ltd and Remedium Lifecare Ltd?

As of June 14, 2026, the Norris Medicines Ltd stock price is INR ₹14.11. On the other hand, Remedium Lifecare Ltd stock price is INR ₹0.28.

How do dividend payouts of Norris Medicines Ltd and Remedium Lifecare Ltd compare?

To compare the dividend payouts of Norris Medicines Ltd and Remedium Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.